Literature DB >> 5348427

The effect of bretylium on intracellular cardiac action potentials in relation to its anti-arrhythmic and local anaesthetic activity.

J G Papp, E M Vaughan Williams.   

Abstract

1. The initial effect of bretylium tosylate on isolated rabbit atria was to increase conduction velocity, contraction heights, spontaneous frequency and maximum driven frequency, and to reduce electrical threshold. At concentrations of 200 mg/l. or less, these were the only effects, and were consistent with the known sympathomimetic actions of bretylium.2. At extremely high concentrations, 1,200 and 2,400 mg/l., the initial actions were succeeded by weak quinidine-like effects; reduced conduction velocity, spontaneous and maximum driven frequencies, and rate of rise of action potential. The electrical threshold was raised, but contraction heights were not reduced.3. The local anaesthetic activity of bretylium, measured by reductions in the frog nerve action potential, was 1/90 that of procaine and 1/300 that of propranolol, on a molar basis.4. Acute pretreatment with bretylium, 20 mg/kg intravenously, significantly increased the amount of infused ouabain required before the appearance of the first signs of atrial arrhythmia in anaesthetized guinea-pigs, but did not prevent ventricular arrhythmias.5. Pretreatment with bretylium 30 mg/kg subcutaneously 24 hr, and again 4 hr before ouabain infusion, increased the dose of ouabain inducing atrial irregularity and slightly but significantly reduced the incidence of ventricular fibrillation.

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 5348427      PMCID: PMC1703703     

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  26 in total

1.  A brief study of the sympathomimetic cardiovascular effects of bretylium.

Authors:  J YELNOSKY; L C MORTIMER
Journal:  Arch Int Pharmacodyn Ther       Date:  1961-02-01

2.  Antisympathomimetic and antifibrillatory effects of pronethalol and propranolol.

Authors:  B G Benfey; D R Varma
Journal:  Br J Pharmacol Chemother       Date:  1966-01

3.  Adrenergic mechanism participating in induction of atrial fibrillation by ACh.

Authors:  K Hashimoto; S Chiba; S Tanaka; M Hirata; Y Suzuki
Journal:  Am J Physiol       Date:  1968-11

4.  Quantitiative comparison of bretylium with other antifibrillatory drugs.

Authors:  M B Bacaner
Journal:  Am J Cardiol       Date:  1968-04       Impact factor: 2.778

5.  Treatment of ventricular fibrillation and other acute arrhythmias with bretylium tosylate.

Authors:  M B Bacaner
Journal:  Am J Cardiol       Date:  1968-04       Impact factor: 2.778

6.  Propranolol, MJ 1999 and Ciba 39089 Ba in ouabain and adrenaline induced cardiac arrhythmias.

Authors:  C Raper; J Wale
Journal:  Eur J Pharmacol       Date:  1968-08       Impact factor: 4.432

7.  Influence of stretch and dynamic functional state of the myocardium on tendency of the heart to arrhythmia.

Authors:  G Papp; L Szekeres
Journal:  Acta Physiol Acad Sci Hung       Date:  1967

8.  Anti-arrhythmic action of bretylium.

Authors:  P E Leveque
Journal:  Nature       Date:  1965-07-10       Impact factor: 49.962

9.  Actions of bretylium and guanethidine on the uptake and release of [3H]-noradrenaline.

Authors:  G HERTTING; J AXELROD; R W PATRICK
Journal:  Br J Pharmacol Chemother       Date:  1962-02

10.  EFFECTS OF BRETYLIUM AND GUANETHIDINE ON HUMAN HAND AND FOREARM VESSELS AND ON THEIR SENSITIVITY TO NORADRENALINE.

Authors:  C J COOPER; J D FEWINGS; R L HODGE; R F WHELAN
Journal:  Br J Pharmacol Chemother       Date:  1963-08
View more
  9 in total

1.  Selective inhibition of K(+)-stimulation of Na,K-ATPase by bretylium.

Authors:  P E Tiku; P T Nowell
Journal:  Br J Pharmacol       Date:  1991-12       Impact factor: 8.739

2.  Effects of octanoate on the electrical activity of Purkinje fibres.

Authors:  J Borbola; J G Papp; L Szekeres
Journal:  Experientia       Date:  1974-03-15

3.  A comparison of the anti-arrhythmic actions of I.C.I. 50172 and (--)-propranolol and their effects on intracellular cardiac action potentials and other features of cardiac function.

Authors:  J G Papp; E M Williams
Journal:  Br J Pharmacol       Date:  1969-10       Impact factor: 8.739

4.  Bretylium tosylate in the management of refractory ventricular fibrillation.

Authors:  R W Dhurandhar; S J Teasdale; W A Mahon
Journal:  Can Med Assoc J       Date:  1971-07-24       Impact factor: 8.262

5.  The effect of altered thyroid state on atrial intracellular potentials.

Authors:  A S Freedberg; J G Papp; E M Williams
Journal:  J Physiol       Date:  1970-04       Impact factor: 5.182

6.  The effect of amiodarone, a new anti-anginal drug, on cardiac muscle.

Authors:  B N Singh; E M Vaughan Williams
Journal:  Br J Pharmacol       Date:  1970-08       Impact factor: 8.739

7.  A third class of anti-arrhythmic action. Effects on atrial and ventricular intracellular potentials, and other pharmacological actions on cardiac muscle, of MJ 1999 and AH 3474.

Authors:  B N Singh; E M Vaughan Williams
Journal:  Br J Pharmacol       Date:  1970-08       Impact factor: 8.739

8.  Effect of adenosine on sinoatrial and ventricular automaticity of the guinea pig.

Authors:  A J Szentmiklósi; M Németh; J Szegi; J G Papp; L Szekeres
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1980-03       Impact factor: 3.000

9.  The effects on cardiac muscle and nerve of a fluorinated decahydroquinoline derivative, L7810, rapidly absorbed after oral administration.

Authors:  E E Bagwell; P Polster; E M Williams
Journal:  Br J Pharmacol       Date:  1973-06       Impact factor: 8.739

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.